Lyra Therapeutics: Clinical Trials

5 trials sponsored by Lyra Therapeutics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 2 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Completed 2
Phase 11Completed 1

Follow Lyra Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2)
LYR-210, Sham procedure control, Background therapy - Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis)
Phase 3CompletedLyra Therapeutics1822022-05-132026-02-19
Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults
LYR-210, Sham procedure control, Background Therapy - Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis)
Phase 3CompletedLyra Therapeutics1962022-01-272025-05-02
LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study)
LYR-220 Design 1 (Part 1 only), LYR-220 Design 2 (Part 1 and Part 2), Bilateral sham procedure control (Part 2) - Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis)
Phase 2CompletedLyra Therapeutics482021-11-232024-12-17
LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)
LYR-210, Sham comparator - Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis)
Phase 2CompletedLyra Therapeutics712019-05-092023-07-25
480 Biomedical Sinus Drug Depot
480 Mometasone Furoate Sinus Drug Depot - Chronic Sinusitis
Phase 1CompletedLyra Therapeutics202017-06-062021-08-25

Conditions studied

Disease (4)

Countries

Australia (3)  ·  Poland (3)  ·  United States (3)  ·  Austria (2)  ·  Czechia (2)  ·  New Zealand (2)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Germany (1)  ·  Hungary (1)  ·  Spain (1)

Results publications

PMID 30645028

NIH funding

2018 (1)